Delivery Order SPE2DB20D3303-SPE2DB25FZ8C9

Award Date 5/16/25
Potential Completion Date 5/19/25
Potential Value $3.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FLUTICASONE PROP HFA 110 MCG 12GM, a pharmaceutical product, and has a ceiling value of $1,331.01. The contract is a firm fixed-price, delivery order contract with an ultimate completion date of April 4, 2025. The award was made on April 3, 2025, and there is no set-aside...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of FLUTICASONE PROP HFA 110 MCG 12GM, a pharmaceutical product. The contract has a ceiling value of $5,219.48 and a period of performance through December 26, 2023. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FLUTICASONE PROP HFA 110 MCG 12GM, a pharmaceutical product, with a ceiling value of $2,256.02 and a period of performance through May 16, 2024. The contract is a firm-fixed-price delivery order and does not have a set-aside designation,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product, with a ceiling value of $3,319.23. The contract has an ultimate completion date of November 21, 2023. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FLUTICASONE PROP HFA 110 MCG 12GM, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $3,297.40 and an ultimate completion date of February 7, 2024. This contract award is not associated with a set-aside...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,376.00 and is for the supply of FLUTICASONE PROP HFA 220 MCG 12GM, a pharmaceutical product. The contract is a firm fixed-price agreement with a completion date of February 12, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product, with a ceiling value of $1,814.56 and a period of performance through April 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific socioeconomic category. AmerisourceBergen Drug Corp holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a prescription medication, with a ceiling value of $15,704.33 and a period of performance through May 1, 2025. The contract is a firm fixed-price, non-set-aside delivery order, indicating open competition. Amerisourcebergen Drug Corp holds...
This is a delivery order federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the supply of FLUTICASONE PROP HFA 110 MCG 12GM, a pharmaceutical product, with a ceiling value of $1,891.24. The contract is a firm fixed price delivery order with a completion date of May 13, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded to Amerisourcebergen Drug Corp, Corporate Office Division, for the supply of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product, to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,649.55 and an ultimate completion date of August 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB25FZ8C9
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FLUTICASONE PROP HFA 44 MCG 10.6GM, a pharmaceutical product, with a ceiling value of $3,184.32. The contract has an ultimate completion date of May 19, 2025 and was awarded on May 16, 2025. This is a firm fixed-price contract, and it is not a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This delivery order contract supports the DLA's mission to provide medical supplies and pharmaceuticals to the U.S. military and other government agencies.

Generated 8/17/25, 12:56 AM